Cambridge Science Festival / Anne Phelan
Join BenevolentAI’s Chief Scientific Officer at Cambridge Science Festival where she will be speaking about Data science, AI and their potential to transform the discovery and development of medicines.
Wired Health w/ Joanna Shields
Join BenevolentAI’s CEO Joanna Shields at Wired Health where she will be speaking about forging new frontiers in drug discovery by uniting human and artificial intelligence
LSX World Congress w/ Jackie Hunter
Join Jackie Hunter at the LSX World Congress where she will discuss AI in drug discovery and development in a panel alongside leaders from Atomwise, Arctoris, Sensyne Health.
ACTT-2 trial results published in the New England Journal of Medicine validate baricitinib’s efficacy in combination with remdesivir in hospitalised COVID-19 patients
Peer-reviewed data from the ACTT-2 further validate BenevolentAI’s hypothesis for baricitinib as a potential COVID-19 treatment.
WHAT WE DO
Why it matters
Data Diversity initiative
Company Registration: 09781806
Terms & Conditions
Privacy & Cookies Policy